GlaxoSmithKline said Monday that some of its senior executives in China appear to have violated the law, the latest development in a high-profile investigation into the company’s operations in the country.
The U.K. drugmaker has been accused by China of using a network of more than 700 travel agencies and other firms to channel bribes to hospitals, doctors and government officials since 2007.
Read Full Article HERE
Charles Riley, CNN via CHINA US Focus http://feedproxy.google.com/~r/ChinaUsFocus/~3/l0blW-K2GUg/
No comments:
Post a Comment